IRF4 and relapsing-remitting multiple sclerosis: Silencing of IL-1R1 gene expression through small-interference RNA (siRNA) in CD4+ T cells derived from relapsing-remitting multiple sclerosis patients inhibited in vitro Th17 cell differentiation via inhibition of interferon regulatory factor 4 (IRF4) expression.